Listed

Strata Critical Medical, Inc.

SRTANasdaqCIK 1779128IndustrialsFiscal year ends Dec 31

Reports and events: 107 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Strata Critical Medical, Inc., Reports and events
FiledFormWhat it isAccession number
2026-10-1516:09 ETSCHEDULE 13DOwnership report, active investor0000899140-26-001108
2026-08-0411:35 ET10-QQuarterly reportPeriod 2026-06-300001628280-26-052256
2026-08-0407:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-052152
2026-06-0316:25 ET8-K5.07 Shareholder vote results0001628280-26-040342
2026-05-0816:50 ETSCHEDULE 13D/AOwnership report, active investor, amended0002126691-26-000005
2026-05-0611:53 ET10-QQuarterly reportPeriod 2026-03-310001628280-26-031032
2026-05-0607:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-030898
2026-04-1617:31 ETSCHEDULE 13D/AOwnership report, active investor, amended0002126691-26-000003
2026-04-1408:54 ETDEF 14AProxy statementPeriod 2026-05-280001140361-26-014530
2026-04-0817:03 ETSCHEDULE 13D/AOwnership report, active investor, amended0002126691-26-000002
2026-04-0717:01 ETSCHEDULE 13DOwnership report, active investor0002126691-26-000001
2026-03-0311:52 ET10-KAnnual reportPeriod 2025-12-310001628280-26-013628
2026-03-0307:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-013553
2026-02-0509:09 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-010689
2025-12-0317:18 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-25-118180
2025-12-0215:14 ET8-K/A2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001628280-25-054709
2025-11-1011:51 ET10-QQuarterly reportPeriod 2025-09-300001628280-25-050870
2025-11-1007:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-25-050785
2025-09-1608:34 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001779128-25-000114
2025-09-1217:00 ET8-K/A5.07 Shareholder vote results0001779128-25-000102
2025-08-2908:31 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-085185
2025-08-2908:29 ET8-K/A5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-25-085182
2025-08-0512:43 ET10-QQuarterly reportPeriod 2025-06-300001779128-25-000060
2025-08-0507:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-25-000058
2025-08-0407:01 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-25-073338
2025-05-1211:27 ET10-QQuarterly reportPeriod 2025-03-310001779128-25-000042
2025-05-1207:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-25-000039
2025-05-0817:27 ET8-K5.07 Shareholder vote results0001779128-25-000037
2025-03-2416:33 ETDEF 14AProxy statementPeriod 2025-05-060001140361-25-010039
2025-03-1314:17 ET10-KAnnual reportPeriod 2024-12-310001779128-25-000010
2025-03-1307:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-25-000007
2024-11-1212:20 ET10-QQuarterly reportPeriod 2024-09-300001779128-24-000126
2024-11-1207:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-24-000123
2024-08-0817:44 ET10-QQuarterly reportPeriod 2024-06-300001779128-24-000097
2024-08-0716:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-24-000095
2024-07-1219:31 ETSC 13DOwnership report, active investor0001679688-24-000077
2024-05-0713:54 ET10-QQuarterly reportPeriod 2024-03-310001779128-24-000068
2024-05-0707:42 ET8-K5.07 Shareholder vote results0001779128-24-000064
2024-05-0707:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-24-000062
2024-03-2217:00 ETDEF 14AProxy statementPeriod 2024-05-020001140361-24-014831
2024-03-2216:35 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001779128-24-000047
2024-03-2008:22 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001779128-24-000040
2024-03-1217:07 ET10-KAnnual reportPeriod 2023-12-310001779128-24-000015
2024-03-1207:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-24-000012
2023-11-0807:40 ET10-QQuarterly reportPeriod 2023-09-300001779128-23-000121
2023-11-0807:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-23-000119
2023-08-0908:29 ET10-QQuarterly reportPeriod 2023-06-300001779128-23-000077
2023-08-0907:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001779128-23-000075
2023-05-1116:52 ET8-K5.07 Shareholder vote results0001779128-23-000056
2023-05-1108:51 ET10-QQuarterly reportPeriod 2023-03-310001779128-23-000052

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:13 ET. Listed shows no prices and gives no investment advice.